Skip to main content

Health

More in Health

Gene TherapyExplainer

FDA Approves First Gene Therapy for Rare Metabolic Disorder, Glycogen Storage Disease Type Ia

Clinical Researchers 35%Patient Advocacy Groups 35%Industry Analysts 30%

3 sources · 18d ago

ExplainerLymphoma Treatment

FDA-Approved Cancer Drug Epcoritamab Misses Overall Survival Endpoint in Confirmatory Phase 3 Trial

Regulatory Watchdogs 35%Clinical Oncologists 35%Drug Developers 30%

5 sources · 19d ago

Metabolic HealthClinical Trial Results

First-in-Class GLP-1 Antagonist Slashes Hypoglycemia Risk by 55% in Phase 3 Trial for Post-Bariatric Surgery Complication

Endocrinologists & Surgeons 41%PBH Patients 41%Metabolic Researchers 18%

6 sources · 19d ago

ExplainerPrecision Psychiatry

Landmark Study Finds Biomarker-Guided Antidepressant Selection Boosts Response Rates by 67%

Precision Psychiatry Researchers 40%Clinical Pragmatists 40%Patient Advocates 20%

2 sources · 19d ago

Eating DisordersMedical Breakthrough

Landmark Global Study Finds Distinct 'Metabo-Psychiatric' Genetic Profiles for Binge Eating and Anorexia Nervosa

Psychiatric Geneticists 35%Clinical Researchers 35%Patient Advocates 30%

3 sources · 17d ago

ExplainerPersonalized Oncology

First Personalized mRNA Cancer Vaccine Clears Phase 3 Trial for Melanoma

Oncology Researchers 40%Patient Advocates 30%Regulatory Evaluators 30%

6 sources · 19d ago

ExplainerGenetic Heart Disease

Gene Therapy Restores Heart Function in Genetic Cardiomyopathy Models, Spares Need for Transplants

Molecular Geneticists 40%Pediatric Cardiology Researchers 35%Clinical Analysts 25%

3 sources · 17d ago

ExplainerCardiovascular Care

Centuries-Old Heart Drug Digoxin Slashes Hospitalizations by 25% in Landmark Studies

Clinical Researchers 40%Public Health Advocates 35%Cautious Practitioners 25%

6 sources · 18d ago